CEPI: preparing for future pandemics
Contributing to faster vaccine development and better preparedness for future pandemics: CEPI plays a key global role in accelerating vaccine innovation and strengthening preparedness worldwide.
Discover how CEPI works and how they contribute to the Global Health Hub.
About CEPI
The Coalition for Epidemic Preparedness Innovations (CEPI) is a global public-private partnership dedicated to better preparing the world for epidemics and pandemics.
CEPI works with governments, industry, academia, and civil society organizations to enable rapid and equitable access to vaccines. With a strong focus on low- and middle-income countries.
CEPI in a nutshell
You can turn to CEPI for:
Knowledge and expertise
- Vaccine development and clinical research
- Epidemic modelling and response strategies
- Innovative technology platforms
Network and collaboration
- A global network of governments, industry, NGOs and knowledge institutions
- Partnerships with international organisations and funding bodies
Innovation and funding
- Investments in new technologies
- Support for research projects
- Access to international funding programmes
Impact and policy
- Raising awareness of pandemic preparedness
- Bridging science, policy, and industry
Key themes
- Vaccine development
- Epidemic response
- Innovation in R&D
- Equitable access to vaccines
Role within the Global Health Hub Netherlands
- Active in the Community of Practice 2: Improving international pandemic preparedness and minimising cross-border health threats
- Knowledge sharing on pandemic preparedness
- Connecting international and Dutch partners
- Accelerating innovation and collaboration
Want to learn more about CEPI?
Read the interview with Willo Brock and discover:
- how CEPI supports pandemic preparedness
- what challenges exist
- how collaboration makes a difference
Collaborating with CEPI
Interested in collaborating, exchanging knowledge, or joining CEPI initiatives? Visit their website: https://cepi.net. Follow CEPI on LinkedIn, Bluesky, Facebook and X.